{"database": "lobbying", "table": "lobbying_activities", "rows": [[2263150, "c7d454c6-ce35-4bfb-835a-91fd68a99c1a", "Q1", "SQUIRE PATTON BOGGS", 30906, "THE PROCTER AND GAMBLE COMPANY", 2019, "first_quarter", "CSP", "In support of passage of H.R. 269, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, legislation to update the US Food & Drug Administration's OTC monograph process.", "HOUSE OF REPRESENTATIVES", 0, 0, "2019-04-09T16:33:53.877000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2263150"], "units": {}, "query_ms": 0.5527830217033625, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}